ArticleJournal of anesthesia and translational medicine2024
Substantial challenge for a patient with severe mitral regurgitation and pulmonary hypertension undergoing transcatheter mitral valve edge-to-edge repair procedure.
Article in Journal of anesthesia and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The transcatheter mitral valve edge-to-edge repair (TEER) procedure is a percutaneous transcatheter intervention for severe mitral regurgitation in patients deemed to have significant comorbidities. It is considered a minimally invasive procedure. However, pulmonary hypertension as a common concomitant pathology with mitral regurgitation makes anesthetic management of the procedure challenging and may lead to unexpected perioperative adverse events. We present a case highlighting 2 distinctive intraoperative events of a patient with severe mitral regurgitation and pulmonary hypertension undergoing the TEER procedure: (1) rapid and profound cardiogenic shock after apnea episode and (2) significant right-to-left shunt of iatrogenic residual atrial septal defect after clip deployment, where pulmonary hypertension played a pivotal role in both events. An in-depth understanding of the pathophysiology of mitral regurgitation and the TEER procedure sets the foundation for risk assessment and anesthesia planning. Moreover, application of transesophageal echocardiography is essential in resuscitation optimization and surgical decision making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.